{"id": 779787964947763200, "geo": null, "lang": "en", "text": "RT @FundRx: Exciting that companies like @amgen @TevaUSA and @LillyPad are testing new antibody medications for migraines https://t.co/qPN2\u2026", "user": {"id": 183626808, "url": "http://t.co/PlXHLByVXo", "lang": "en", "name": "Teva Pharmaceuticals", "id_str": "183626808", "entities": {"url": {"urls": [{"url": "http://t.co/PlXHLByVXo", "indices": [0, 22], "display_url": "tevausa.com", "expanded_url": "http://www.tevausa.com"}]}, "description": {"urls": [{"url": "https://t.co/gsGkRP8J3A", "indices": [136, 159], "display_url": "ow.ly/UZcKg", "expanded_url": "http://ow.ly/UZcKg"}]}}, "location": "United States", "verified": false, "following": true, "protected": false, "time_zone": null, "created_at": "Fri Aug 27 13:45:33 +0000 2010", "utc_offset": null, "description": "Official Teva US Twitter feed. We don't just make medicines, we make a difference in people's lives. Managed by Corp Comms. Guidelines: https://t.co/gsGkRP8J3A", "geo_enabled": false, "screen_name": "TevaUSA", "listed_count": 108, "friends_count": 1167, "is_translator": false, "notifications": false, "statuses_count": 1799, "default_profile": false, "followers_count": 5772, "translator_type": "none", "favourites_count": 855, "profile_image_url": "http://pbs.twimg.com/profile_images/1114240566001315840/wwBtyZu1_normal.png", "profile_banner_url": "https://pbs.twimg.com/profile_banners/183626808/1517338835", "profile_link_color": "94D487", "profile_text_color": "000000", "follow_request_sent": false, "contributors_enabled": false, "has_extended_profile": false, "default_profile_image": false, "is_translation_enabled": false, "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/1114240566001315840/wwBtyZu1_normal.png", "profile_background_color": "94D487", "profile_sidebar_fill_color": "000000", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png", "profile_sidebar_border_color": "000000", "profile_use_background_image": false, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png"}, "place": null, "id_str": "779787964947763200", "source": "<a href=\"http://twitter.com/download/iphone\" rel=\"nofollow\">Twitter for iPhone</a>", "entities": {"urls": [], "symbols": [], "hashtags": [], "user_mentions": [{"id": 2607734142, "name": "FundRx", "id_str": "2607734142", "indices": [3, 10], "screen_name": "FundRx"}, {"id": 28436760, "name": "Amgen", "id_str": "28436760", "indices": [41, 47], "screen_name": "Amgen"}, {"id": 183626808, "name": "Teva Pharmaceuticals", "id_str": "183626808", "indices": [48, 56], "screen_name": "TevaUSA"}, {"id": 172496840, "name": "Eli Lilly and Company", "id_str": "172496840", "indices": [61, 70], "screen_name": "LillyPad"}]}, "favorited": false, "retweeted": false, "truncated": false, "created_at": "Sat Sep 24 21:01:53 +0000 2016", "coordinates": null, "contributors": null, "retweet_count": 1, "favorite_count": 0, "is_quote_status": false, "retweeted_status": {"id": 779773725851787265, "geo": null, "lang": "en", "text": "Exciting that companies like @amgen @TevaUSA and @LillyPad are testing new antibody medications for migraines https://t.co/qPN22eAH0y", "user": {"id": 2607734142, "url": "https://t.co/4D3K6UIhvu", "lang": "en", "name": "FundRx", "id_str": "2607734142", "entities": {"url": {"urls": [{"url": "https://t.co/4D3K6UIhvu", "indices": [0, 23], "display_url": "fundrx.com", "expanded_url": "http://fundrx.com"}]}, "description": {"urls": []}}, "location": "NYC", "verified": false, "following": false, "protected": false, "time_zone": null, "created_at": "Sun Jul 06 15:59:37 +0000 2014", "utc_offset": null, "description": "FundRx is a healthcare venture capital firm and platform.", "geo_enabled": false, "screen_name": "FundRx", "listed_count": 18, "friends_count": 833, "is_translator": false, "notifications": false, "statuses_count": 271, "default_profile": false, "followers_count": 401, "translator_type": "none", "favourites_count": 82, "profile_image_url": "http://pbs.twimg.com/profile_images/634738748677230593/GeshxcoS_normal.png", "profile_banner_url": "https://pbs.twimg.com/profile_banners/2607734142/1440167288", "profile_link_color": "ABB8C2", "profile_text_color": "000000", "follow_request_sent": false, "contributors_enabled": false, "has_extended_profile": false, "default_profile_image": false, "is_translation_enabled": false, "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/634738748677230593/GeshxcoS_normal.png", "profile_background_color": "000000", "profile_sidebar_fill_color": "000000", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png", "profile_sidebar_border_color": "000000", "profile_use_background_image": false, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png"}, "place": null, "id_str": "779773725851787265", "source": "<a href=\"http://twitter.com/download/iphone\" rel=\"nofollow\">Twitter for iPhone</a>", "entities": {"urls": [{"url": "https://t.co/qPN22eAH0y", "indices": [110, 133], "display_url": "statnews.com/2016/09/23/mig\u2026", "expanded_url": "https://www.statnews.com/2016/09/23/migraine-new-treatments/"}], "symbols": [], "hashtags": [], "user_mentions": [{"id": 28436760, "name": "Amgen", "id_str": "28436760", "indices": [29, 35], "screen_name": "Amgen"}, {"id": 183626808, "name": "Teva Pharmaceuticals", "id_str": "183626808", "indices": [36, 44], "screen_name": "TevaUSA"}, {"id": 172496840, "name": "Eli Lilly and Company", "id_str": "172496840", "indices": [49, 58], "screen_name": "LillyPad"}]}, "favorited": false, "retweeted": false, "truncated": false, "created_at": "Sat Sep 24 20:05:18 +0000 2016", "coordinates": null, "contributors": null, "retweet_count": 1, "favorite_count": 1, "is_quote_status": false, "possibly_sensitive": false, "in_reply_to_user_id": null, "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}, "in_reply_to_user_id": null, "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}